pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
REGENERON PHARMACEUTICALS · news · pharmadog
← back to REGENERON PHARMACEUTICALS
News mentioning REGENERON PHARMACEUTICALS
43
stories
Jul 10, 26
ARPA-H puts $160M into bespoke drug therapies; Biohaven switches up scientific leadership
biopharma dive
Jun 30, 26
Ipsen’s $450M blood cancer drug; FDA selects first cohort for “pre-check” pilot program
biopharma dive
Jun 29, 26
FDA Selects Seven Participants for PreCheck Pilot Program to Advance U.S. Drug Manufacturing
fda press
Jun 11, 26
Sensorion, citing Regeneron competition, shifts focus to a different hearing loss therapy
biopharma dive
Jun 10, 26
Parabilis sets a record with a $670M biotech IPO
biopharma dive
Jun 3, 26
NewLimit’s $435M megaround; Lilly’s busy dealmaking week
biopharma dive
May 18, 26
Regeneron's Phase 3 skin cancer miss adds to mounting failures in LAG-3
endpoints
May 6, 26
Cases and Conversations™: Next-Generation Pathology Advances and Considerations for Precision Care in Non–Small Cell Lung Cancer
onclive
May 6, 26
STAT+: Even at a meeting in Rome, FDA shifts are top of mind for gene therapy field
stat
Apr 28, 26
Coultreon banks $125M to support testing of former Galapagos immune drug
biopharma dive
Apr 24, 26
Lilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelics
biopharma dive
Apr 24, 26
STAT+: Pharmalittle: We’re reading about a Trump deal with Regeneron, reclassifying medical marijuana, and more
stat
Apr 23, 26
FDA approves Regeneron’s hearing loss gene therapy
biopharma dive
← prev
page 2 of 2
next →
